Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -9.87 % |
3 Month Return | -12.32 % |
1 Year Return | + 12.06 % |
Market Stats | |
Previous Close | ₹1,465.10 |
Open | ₹1,465.10 |
Volume | 2,629.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹2,070.24Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹2,070.24 Cr |
P/B Ratio | 2.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Diversified |
ROE | 6.46 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹2,070.24 Cr | 33.73% | 0.51 | NA | NA | |
NA | ₹53.63 Cr | 114.74% | 0.84 | ₹5 Cr | ₹21 Cr | |
NA | ₹77.98 Cr | 26.42% | 0.54 | ₹3 Cr | ₹9 Cr | |
NA | ₹179.54 Cr | 328.6% | 0.50 | ₹1 Cr | ₹2 Cr | |
NA | ₹3,693.51 Cr | 13.36% | 0.54 | ₹199 Cr | ₹2,339 Cr |
Organisation | TTK Healthcare Ltd |
Headquarters | |
Industry | Diversified |
E-voting on shares | Click here to vote |
Key events for TTK Healthcare Ltd
TTK Healthcare's standalone net sales for September 2024 reached Rs 198.49 crore, up 6.85% YoY. Net profit increased by 7.46% to Rs 17.20 crore, while EBITDA rose 1.41%. EPS improved to Rs 12.17. However, shares have seen a -3.21% decline over the last 6 months but a 26.78% increase over the past year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 1.87% to 1.90% in Sep 2024 quarter
Price Rise
In the last 7 days, TTKHLTCARE stock has moved up by 3.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.56% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 46.5%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 1.6%
Retail Holding Down
Retail Investor have decreased holdings from 22.43% to 22.40% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 74.56% | 0.00 | |
Foreign Institutions | 1.9% | 1.82 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 22.4% | ||
Others | 1.13% | 0.00 |
TTK Healthcare Ltd’s net profit jumped 7.43% since last year same period to ₹17.20Cr in the Q2 2024-2025. On a quarterly growth basis, TTK Healthcare Ltd has generated -45.54% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, TTK Healthcare Ltd has declared dividend of ₹10 - translating a dividend yield of 0.68%.
Read More about DividendsBearish
Neutral
Bullish
TTK Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.
TTK Healthcare Ltd (TTKHLTCARE) share price today is ₹1448.35
TTK Healthcare Ltd is listed on NSE
TTK Healthcare Ltd is listed on BSE
Today’s traded volume of TTK Healthcare Ltd(TTKHLTCARE) is 2,629.00.
Today’s market capitalisation of TTK Healthcare Ltd(TTKHLTCARE) is ₹2070.24Cr.
TTK Healthcare Ltd(TTKHLTCARE | Price |
---|---|
52 Week High | ₹1893.95 |
52 Week Low | ₹1272 |
TTK Healthcare Ltd(TTKHLTCARE) share price is ₹1448.35. It is down -23.53% from its 52 Week High price of ₹1893.95
TTK Healthcare Ltd(TTKHLTCARE) share price is ₹1448.35. It is up 13.86% from its 52 Week Low price of ₹1272
TTK Healthcare Ltd(TTKHLTCARE | Returns |
---|---|
1 Day Returns | -16.75% |
1 Month Returns | -9.87% |
3 Month Returns | -12.32% |
1 Year Returns | 12.06% |